Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 19,070 | 24,733 | 17,964 | 24,696 | 20,510 |
| Operating Income | -19,070 | -24,733 | -17,964 | -24,696 | -20,510 |
| Other Income | 1,611 | 13,517 | 11,469 | -19,490 | 97,481 |
| Pre-tax Income | -17,459 | -11,216 | -6,495 | -44,186 | 76,971 |
| Net Income Continuous | -17,459 | -11,216 | -6,495 | -44,617 | 76,971 |
| Net Income | $-17,459 | $-11,216 | $-6,495 | $-44,617 | $76,971 |
| EPS Basic Total Ops | -0.21 | -0.13 | -0.08 | -0.14 | 1.05 |
| EPS Basic Continuous Ops | -0.23 | -0.15 | -0.08 | -0.38 | 1.48 |
| EPS Diluted Total Ops | -0.21 | -0.13 | -0.08 | 1.19 | -0.28 |
| EPS Diluted Continuous Ops | -0.23 | -0.15 | -0.08 | -0.28 | 1.39 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.13 | -0.08 | -0.64 | -0.32 |
| EBITDA(a) | $-19,070 | $-24,733 | $-17,964 | $-24,696 | $-20,510 |